Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase EARLY_PHASE1 1

Status

Recruiting 3Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 4NIH 1

Study Type

Interventional 3Observational 2

Sponsor

Cancer Type

Thoracic 8Gastrointestinal 5Genitourinary 4Breast 3Head & Neck 2Gynecologic 2CNS 2Tumor-Agnostic 1

Conditions

Pancreatic Neoplasms 2Stomach Neoplasms 1Rectal Neoplasms 1Pancreatitis, Chronic 1Immunoglobulin G4-Related Disease 1Autoimmune Pancreatitis 1Anus Neoplasms 1Anal Canal Carcinoma 1

Interventions

Specimen Handling 74Fluorouracil 72Oxaliplatin 64Leucovorin 55Magnetic Resonance Spectroscopy 52Bevacizumab 48Gemcitabine 41Biopsy 40Capecitabine 38Nivolumab 31Irinotecan 31Cisplatin 30pembrolizumab 28durvalumab 28Cetuximab 22Paclitaxel 20dehydroftorafur 19Folfox protocol 19atezolizumab 18130-nm albumin-bound paclitaxel 16Radiotherapy 15Radiation 15Taxes 14Carboplatin 13Albumin-Bound Paclitaxel 13tremelimumab 11X-Rays 11Surgical Procedures, Operative 11trastuzumab deruxtecan 10lenvatinib 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Observation × Gastrointestinal × 30 days × Clear all
NCT03594630 2026-05-20

Active Surveillance and Chemotherapy Before Surgery in Treating Participants With Stage II-III Rectal Cancer

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Recruiting
120 enrolled
Gastrointestinal

Rectal Neoplasms

NCT07536841 2026-05-19

ОС26

Military Medical Clinical Center of the Southern Region, Ukraine

Not yet recruiting
82 enrolled
Gastrointestinal

Immunoglobulin G4-Related Disease, Autoimmune Pancreatitis, Pancreatic Neoplasms, Pancreatitis, Chronic

NCT07587229 2026-05-14

Alternative Splicing Based Prediction of Chemotherapy Response in Gastric Cancer

City of Hope Medical Center

Recruiting
329 enrolled
Gastrointestinal

Stomach Neoplasms

NCT03233711 2026-05-13

Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer

National Cancer Institute (NCI)

Phase 3 Active not recruiting
344 enrolled
Gastrointestinal

Anal Canal Carcinoma, Anus Neoplasms

NCT06958328 2026-05-04

LAP100

NRG Oncology

Phase 3 Recruiting
356 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡